14,860 Shares in Penumbra, Inc. (NYSE:PEN) Acquired by EFG Asset Management North America Corp.

EFG Asset Management North America Corp. bought a new position in Penumbra, Inc. (NYSE:PEN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,860 shares of the company's stock, valued at approximately $3,531,000.

Other institutional investors and hedge funds have also modified their holdings of the company. China Universal Asset Management Co. Ltd. acquired a new stake in Penumbra during the 4th quarter worth about $573,000. State Street Corp lifted its position in Penumbra by 0.3% in the 3rd quarter. State Street Corp now owns 1,236,671 shares of the company's stock worth $240,298,000 after buying an additional 3,863 shares in the last quarter. E. Ohman J or Asset Management AB boosted its stake in shares of Penumbra by 10.4% during the 4th quarter. E. Ohman J or Asset Management AB now owns 21,312 shares of the company's stock valued at $5,061,000 after buying an additional 2,000 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Penumbra by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 271,574 shares of the company's stock valued at $64,493,000 after acquiring an additional 3,807 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of Penumbra by 1.7% in the third quarter. Geode Capital Management LLC now owns 655,572 shares of the company's stock worth $127,417,000 after acquiring an additional 11,257 shares during the last quarter. Hedge funds and other institutional investors own 88.88% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on PEN. Royal Bank of Canada boosted their target price on Penumbra from $285.00 to $313.00 and gave the company an "outperform" rating in a research note on Wednesday, February 19th. UBS Group increased their price objective on Penumbra from $305.00 to $320.00 and gave the stock a "buy" rating in a report on Wednesday, February 19th. Morgan Stanley lifted their target price on shares of Penumbra from $240.00 to $260.00 and gave the company an "equal weight" rating in a research note on Wednesday, February 19th. Truist Financial increased their price target on shares of Penumbra from $285.00 to $325.00 and gave the stock a "buy" rating in a research note on Wednesday, February 19th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Penumbra from $230.00 to $285.00 and gave the company an "overweight" rating in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Penumbra currently has a consensus rating of "Moderate Buy" and an average price target of $294.47.

Remove Ads

Penumbra Price Performance

NYSE:PEN traded down $2.47 during mid-day trading on Friday, hitting $267.16. The company's stock had a trading volume of 304,864 shares, compared to its average volume of 404,370. The company has a market capitalization of $10.29 billion, a price-to-earnings ratio of 785.75, a P/E/G ratio of 2.83 and a beta of 0.51. The stock has a fifty day moving average of $274.55 and a 200-day moving average of $242.90. Penumbra, Inc. has a fifty-two week low of $148.00 and a fifty-two week high of $310.00. The company has a current ratio of 6.01, a quick ratio of 3.25 and a debt-to-equity ratio of 0.02.

Penumbra (NYSE:PEN - Get Free Report) last announced its earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.88 by $0.09. The business had revenue of $315.52 million during the quarter, compared to analysts' expectations of $311.63 million. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. As a group, equities analysts forecast that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

Insider Activity

In other news, CFO Maggie Yuen sold 2,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $286.00, for a total transaction of $572,000.00. Following the transaction, the chief financial officer now directly owns 15,243 shares in the company, valued at approximately $4,359,498. This represents a 11.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Johanna Roberts sold 600 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $287.43, for a total transaction of $172,458.00. Following the sale, the executive vice president now directly owns 66,539 shares in the company, valued at $19,125,304.77. This trade represents a 0.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 93,518 shares of company stock worth $26,400,219. Insiders own 5.00% of the company's stock.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.